Balyasny Asset Management »

Rapt Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $520k 58k 8.98
2023-06-30 $2.7M 145k 18.70
2023-03-31 $1.9M 101k 18.35
2021-09-30 $1.0M 33k 31.06
2021-06-30 $1.4M 46k 31.79

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Apple (AAPL)
Select Sector Spdr Tr Financial (XLF)
Pioneer Natural Resources Put Option (PXD)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
JPMorgan Chase & Co. Call Option (JPM)
Hess Call Option (HES)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom Call Option (AVGO)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Asml Holding N V N Y Registry Shs Call Option (ASML)

View all positions for Balyasny Asset Management

Top funds holding Rapt Therapeutics

FMR
Column Group
Vanguard Group
BlackRock
T. Rowe Price Associates
Morgan Stanley
Kingdon Capital Management
Perceptive Advisors
Geode Capital Management
Redmile Group
State Street Corporation
Euclidean Capital
Affinity Asset Advisors
Dimensional Fund Advisors
Alphabet

View all funds holding Rapt Therapeutics